Jianping Hu
Impact in
-
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
-
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- Protein Degradation and Inhibitors 4
- Melanoma and MAPK Pathways 2
- Ubiquitin and proteasome pathways 1
-
- Cardiovascular Effects of Exercise 1
- Cardiac electrophysiology and arrhythmias 1
- Co-authors
- Jian Jin (4 shared papers)Yunuo Zhao (1 shared paper)Xinyu Guo (1 shared paper)Hao Zhang (1 shared paper)Yujie Zhao (1 shared paper)Jing Jing (1 shared paper)Hubing Shi (1 shared paper)Xiaomeng Yin (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)Renal Failure (1 paper)European Journal of Medicinal Chemistry (1 paper)International Immunopharmacology (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Jianping Hu
12 papers receiving 540 citations
Jianping Hu's Hit Papers
Peers
Comparison fields: 5 of 69
- Oncology 190
- Immunology 116
- Hematology 44
- Cancer Research 50
- Molecular Biology 239
Countries citing papers authored by Jianping Hu
This map shows the geographic impact of Jianping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Hu more than expected).
Fields of papers citing papers by Jianping Hu
This network shows the impact of papers produced by Jianping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Hu. The network helps show where Jianping Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianping Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance Hit paper breakdown → | 2023 | 237 |
| 2 | 2011 | 111 | |
| 3 | 2022 | 69 | |
| 4 | 2019 | 56 | |
| 5 | 2020 | 30 | |
| 6 | 2013 | 23 | |
| 7 | 2023 | 7 | |
| 8 | 2012 | 3 | |
| 9 | 2017 | 3 | |
| 10 | 2023 | 2 | |
| 11 | 2024 | 2 | |
| 12 | 2025 | 1 | |
| 13 | 2025 | 0 | |
| 14 | 2025 | 0 |
About Jianping Hu
Jianping Hu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology, Epidemiology and Hematology, having authored 14 papers that have together received 544 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (4 papers), Melanoma and MAPK Pathways (2 papers), Multiple Myeloma Research and Treatments (2 papers), Trypanosoma species research and implications (1 paper), Liver Diseases and Immunity (1 paper), Cardiovascular Effects of Exercise (1 paper), Cardiac electrophysiology and arrhythmias (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Oncology (190 citations), Immunology (116 citations), Hematology (44 citations), Cancer Research (50 citations) and Molecular Biology (239 citations). Jianping Hu has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Jian Jin, Yunuo Zhao, Xinyu Guo, Hao Zhang, Yujie Zhao, Jing Jing, Hubing Shi, Xiaomeng Yin, Hu Zhang and Xuelei Ma. Their work appears in journals such as Journal of Medicinal Chemistry, Renal Failure, European Journal of Medicinal Chemistry, International Immunopharmacology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.